← Back
$RYTM All transactions

RHYTHM PHARMACEUTICALS, INC.

M 10b5-1 Plan

$ Value

$0

Shares

65,431

Price

$0

Filed

Jun 5

Insider

Name

MCGIRR DAVID W J

Title

CIK

0001219023

Roles

Director

Transaction Details

Transaction Date

2025-06-03

Code

M

Table

Derivative

Ownership

Direct

Equity Swap

No

Shares After

Footnotes

The sale reported in this Form 4 was effected pursuant to Rule 10b5-1 plan adopted by the Reporting Person on February 28, 2025. | The price reported in Column 4 is a weighted average price. The securities were sold in multiple transactions at prices ranging from $64.59 to $65.58 per common stock. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. | The price reported in Column 4 is a weighted average price. The securities were sold in multiple transactions at prices ranging from $65.59 to $65.81 per common stock. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. | The stock option is fully vested.

Filing Info

Accession No.

0001104659-25-056844

Form Type

4

Issuer CIK

0001649904

MCGIRR DAVID W J's History

Date Ticker Type Value
2025-06-24 RYTM A $0
2025-06-24 RYTM A $0
2025-06-18 RYTM M
2025-06-18 RYTM M $0
2025-06-09 XFOR A $0
2025-06-04 INSM $220K
2025-06-03 INSM $232K
2025-06-03 RYTM M $300K
2025-06-03 RYTM $3.6M
2025-06-03 RYTM $648K

Other Insiders at RYTM (90d)

Insider Bought Sold Last
German Christopher Paul
Corporate Controller & CAO
2026-02-01
Popovits Kimberly J 2026-04-01
Meeker David P
President and CEO
2026-02-01
Smith Hunter C
Chief Financial Officer
$703K 2026-02-05
Mazabraud Yann
EVP, Head of International
2026-04-01
Lee Jennifer Kayden
EVP, Head of North America
2026-02-01
Cramer Pamela J.
Chief Human Resources Officer
2026-02-01
Shulman Joseph
Chief Technical Officer
2026-02-01
Garfield Alastair
Chief Scientific Officer
2026-02-01